Drugs / Metronidazole gel
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03769688 Background | Mar 2022 → Dec 2023 | bacterial vaginosis | Johns Hopkins University | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metronidazole gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03769688 ↗ |
| Route | Other | “5 day course of vaginal MetroGel will be used prior to VMT intervention.” NCT03769688 ↗ |